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Summary
Certain microbes evade host innate immunity by kill-
ing activated macrophages with the help of virulence
factors that target prosurvival pathways. For instance,
infection of macrophages with the TLR4-activating
bacterium Bacillus anthracis triggers an apoptotic re-
sponse due to inhibition of p38 MAP kinase activation
by the bacterial-produced lethal toxin. Other patho-
gens induce macrophage apoptosis by preventing ac-
tivation of NF-B, which depends on IB kinase 
(IKK). To better understand how p38 and NF-B
maintain macrophage survival, we searched for target
genes whose products prevent TLR4-induced apopto-
sis and a p38-dependent transcription factor required
for their induction. Here we describe key roles for
transcription factor CREB, a target for p38 signaling,
and the plasminogen activator 2 (PAI-2) gene, a target
for CREB, in maintenance of macrophage survival.*Correspondence: karinoffice@ucsd.eduIntroduction
Macrophages are professional phagocytes that are key
players in host defense against microbial infection (Ad-
erem and Underhill, 1999). In addition to central depots
in secondary lymphoid organs, macrophages reside in
almost all tissues, serving as sentinels that detect mi-
crobial invaders. Upon recognition of pathogen-associ-
ated molecular patterns (PAMPs; Janeway and Medzhi-
tov, 2002) or molecules released by damaged host
cells, referred to as “danger signals” (Matzinger, 2002),
macrophages produce cytokines, chemokines, and
other inflammatory mediators that alert the remainder
of the immune system to occurrence of infection and
injury. Several distinct classes of receptor proteins par-
ticipate in PAMP sensing and triggering of signaling
cascades that culminate in expression of immune ef-
fector genes. Among such receptors, Toll-like receptors
(TLR) were extensively studied in both vertebrates and
invertebrates (Akira and Takeda, 2004; Beutler, 2004).
Although different TLRs are activated by distinct ago-
nists, their cytoplasmic domains share the ability to
transduce PAMP-generated signals to the IκB kinase
(IKK) and mitogen-activated protein kinases (MAPKs),
such as extracellular signal-regulated kinase (ERK),
c-Jun NH2-terminal kinase (JNK), and p38. These effec-
tors elicit target gene induction by modulating subcel-
lular distribution, promoter recruitment, and transcrip-
tional activity of specific transcription factors.
In addition to innate immune functions, TLR4 signal-
ing can also trigger macrophage apoptosis under spe-
cific circumstances (Park et al., 2002, 2004; Hsu et al.,
2004). The TLR4-mediated proapoptotic response re-
quires activation of the dsRNA-responsive protein ki-
nase PKR and inhibition of either p38 MAPK or IKK
signaling. These findings suggest that progression of
innate immune responses may be regulated at the level
of macrophage survival. Of note, certain bacterial path-
ogens target TLR4-initiated antiapoptotic mechanisms
to induce the death of activated macrophages and
thereby evade detection and destruction by the host
immune system. Bacterial toxins or virulence factors
that participate in induction of macrophage apoptosis
were shown to interfere with the IKK and/or MAPK ef-
fector modules of TLR4. For example, Yersinia YopP/J
and Salmonella AvrA inhibit NF-κB activation (Collier-
Hyams et al., 2002; Orth et al., 1999; Schesser et al.,
1998). By contrast, the anthrax bacterium, Bacillus
anthracis, induces apoptosis of TLR4-activated macro-
phages through its lethal toxin (LT), whose lethal factor
(LF) catalytic subunit prevents p38 activation by cleav-
age of the upstream kinase MKK6 (Park et al., 2002).
Compromised macrophage survival is seen upon in-
activation of either the IKKβ subunit of the IKK complex
or p38 MAPK (Hsu et al., 2004). Whereas the transcrip-
tion factor mediating the survival activity of IKKβ is NF-
κB, the target for the survival activity of p38 MAPK is
unknown. Based on the similar sensitivity of macro-
phages lacking either p38 or NF-κB to TLR4-induced
apoptosis, we postulated that p38 may activate a tran-
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320scription factor that synergizes with NF-κB to induce
transcription of gene(s) whose product(s) inhibits apo-
ptosis. We therefore embarked on a search for such a
transcription factor and target genes and found that the
antiapoptotic p38 MAPK signal is relayed to the cAMP-
responsive transcription factor CREB, which in turn co-
operates with NF-κB to induce transcription of the gene
encoding the serpin plasminogen activator inhibitor 2
(PAI-2). In conjunction with the Bcl-2 family protein Bfl-1/
A1, whose expression also requires both p38 and NF-
κB activation, PAI-2 maintains survival of TLR4-acti-
vated macrophages, illustrating unique antiapoptotic
regulatory mechanisms in the TLR4 pathway.
Results
Survival of TLR4-Activated Macrophages
Requires IKK and p38
Incubation of macrophages with B. anthracis LT sensi-
tizes them to TLR4-dependent apoptosis through inhi-
bition of p38 activation (Park et al., 2002). Although
B. anthracis is a gram-positive bacterium that does not
produce lipopolysaccharide (LPS), it activates TLR4 via
its hemolysin-anthrolysin O (ALO) (Park et al., 2004).
Besides p38, macrophage survival after TLR4 engage-
ment requires activation of IKKβ (Hsu et al., 2004).
These findings suggest that expression of crucial mac-
rophage survival genes, whose products prevent TLR4-
induced apoptosis, requires activation of both signaling
pathways. To eliminate the possibility that the manner
in which IKKβ has been inactivated influences the re-
sults, we used two different populations of IKKβ-defi-
cient macrophages: fetal liver-derived macrophages
(FLDMs) from Ikkb−/− mouse embryos and bone mar-
row-derived macrophages (BMDMs) from LysM-Cre/
IkkbF/F adult mice, referred to as IkkbDmye. Ikkb−/−
FLDMs did not express any IKKβ, whereas IKKα and
IKKγ levels remained unaltered (Figure 1A). On the other
hand, the extent of Ikkb deletion and IKKβ levels in bulk
BMDM cultures derived from IkkbDmye mice varied to a
substantial degree (data not shown). Among indepen-
dently generated BMDMs, we used a population that
exhibited extensive (90%–95%) deletion of the floxed
IkkbF allele, such that most cells did not contain IKKβ
(Figure 1A).
We first checked the sensitivity of these cells to apo-
ptosis caused by infection with the Sterne strain of
B. anthracis. We previously showed that the B. anthra-
cis-induced macrophage apoptosis requires functional
TLR4 (Hsu et al., 2004), which is activated by ALO (Park
et al., 2004). Wild-type (wt) and Ikkb−/− FLDMs un-
derwent apoptosis following B. anthracis infection (Fig-
ure 1B). Preincubation with In-2-LF, a cell-permeable
inhibitor of LF protease activity, prevented B. anthracis-
induced apoptosis of wt but not Ikkb−/− FLDMs (Figure
1B), indicating that macrophage survival requires two
nonredundant signaling components: the LF-sensitive
p38 MAPK and the LF-insensitive IKKβ.
We substantiated the antiapoptotic functions of IKKβ
and p38 MAPK by determining their effect on the kinet-
ics of TLR4-induced macrophage apoptosis. Incuba-
tion of wt or IkkaAA/AA (derived from mice harboring a
nonactivatable allele of Ikka [Cao et al., 2001]) BMDMs
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dith LPS did not result in much apoptotic cell death
ithin the first 24 hr, but TLR4 engagement in IkkbDmye
MDMs caused a robust and rapid apoptotic response
etected as early as 6 hr after LPS addition (Figure 1C).
he kinetics of TLR4-mediated apoptosis in IkkbDmye
MDMs were very similar to those found in wt BMDMs
hose p38 activity was inhibited by either LT or the
mall-molecule inhibitor SB202190 (Figure 1D). Incuba-
ion of macrophages lacking either IKKβ or p38 activity,
ut not wt BMDMs, with ALO also resulted in extensive
poptosis (see Figure S1A in the Supplemental Data
vailable with this article online). Importantly, incuba-
ion of BMDMs with ALO has the same consequences
s their incubation with LPS: resulting in cytokine in-
uction (Park et al., 2004) or apoptosis when combined
ith SB202190 or LT (Figure S1B). To substantiate the
urvival function of p38, we generated BMDMs from
ysM-Cre/p38aF/F (p38aDmye) mice and stimulated them
ith LPS. A p38aDmye BMDM preparation with more
han 90% deletion of the floxed p38aF allele and a com-
arable reduction in p38 activity exhibited normal levels
f ERK and JNK activation and IκBα degradation but
as sensitive to LPS-induced apoptosis just like LT-
nd SB202190-treated macrophages (Figure S2). This
xperiment also underscores the role of the p38α iso-
orm, one of the two SB202190-inhibitable p38 MAPK
sozymes, in survival of TLR4-activated macrophages.
Next we examined LPS-induced NF-κB activation in
kkb−/− FLDMs and IkkbDmye BMDMs. Both types of
KKβ-deficient macrophages exhibited a nearly com-
lete defect in LPS-induced nuclear translocation of
-Rel, whereas nuclear translocation of RelA/p65 was
educed by approximately 50% (Figure 1E). Importantly,
he p38 inhibitor SB202190 (Figure 1E) or LT (data not
hown) did not affect the LPS-induced nuclear translo-
ation of either RelA/p65 or c-Rel.
dentification of p38-Dependent NF-B Target
enes in Macrophages
s p38 appears to have its own regulatory targets
ather than directly affecting NF-κB activation, we
ought to identify a transcription factor that mediates the
urvival function of p38 in TLR4-activated macrophages.
o this end, we examined the promoter sequence of
enes induced by LPS in an IKKβ- and p38-dependent
anner and searched for common transcription factor
inding sites. First, we performed a microarray experi-
ent with RNAs isolated from resting and LPS-stim-
lated J774A.1 macrophage cells. Approximately 1.5%
f the approximately 8000 microarray-analyzed genes
ere found to be LPS inducible (data not shown). We
hen used quantitative real-time PCR (Q-PCR) to con-
irm the LPS inducibility of these genes in BMDMs.
Of the LPS-inducible genes tested by Q-PCR, ap-
roximately 66% were dependent on IKKβ, as their in-
uction was substantially reduced in IKKβ-deficient
acrophages (Figure 2A). Next we examined which of
he IKKβ-dependent genes were affected by inhibition
f p38 MAPK in wt macrophages. Only 57% of the
KKβ-dependent genes exhibited some p38 depen-
ence (Figure 2A; Figure S3). This analysis resulted in
dentification of 14 NF-κB target genes (based on IKKβ
ependence) whose induction by LPS also required
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321Figure 1. The IKKβ/NF-κB and p38 MAPK
Signaling Modules Are Required for Survival
of TLR4-Activated Macrophages
(A) Whole-cell lysates from Ikkb+/+ and Ikkb−/−
FLDMs or IkkbF/F and IkkbDmye (M) BMDMs
were analyzed by immunoblotting with anti-
bodies to IKK subunits. IkkbDmye BMDMs
from line #5 are IKKβ deficient.
(B) Ikkb+/+ and Ikkb−/− FLDMs were infected
with B. anthracis at moi = 0.1 in the absence
or presence of 20 M In-2-LF. After 6 hr, cell
viability was measured by H33258 staining.
Results are expressed as percent cell sur-
vival, with noninfected Ikkb+/+ cells showing
100% survival. The data represent the aver-
age ± SD for three independent experiments.
(C) IkkbF/F, IkkbDmye (IkkbDM; line #5), and
IkkaAA/AA BMDMs were treated with LPS
(100 ng/ml). At different time points, the pro-
portion of apoptotic cells was determined by
Annexin V staining.
(D) BMDMs (C57BL/6J) were preincubated
with DMSO (0.1%; Vehicle), LT (500 ng/ml of
LF + 1 g/ml of PA), or SB202190 (10 M) for
2 hr, and then treated with LPS (100 ng/ml)
and analyzed as in (C).
(E) Macrophages of the indicated Ikkb geno-
types were left untreated or treated with LPS
for 30 min. Immunoblot analysis was per-
formed on cytoplasmic (Cyto) and nuclear
(Nuc) extracts with antibodies against NF-
κB subunits. Where indicated, DMSO and
SB202190 (SB) were added 2 hr before LPS.p38 activation (Figure 2B and data not shown). These
genes included one well-established antiapoptotic gene
(Bfl-1/A1) and several genes (such as Il-1b, Cox-2, Il-6,
and Vcam-1) without an obvious antiapoptotic function.
Comparison of the promoter organization of p38-
dependent and -independent genes revealed that con-
sensus binding sites for basic-region leucine zipper
(bZIP) transcription factors, such as AP-1, C/EBP, and
ATF/CREB, were enriched in p38-dependent gene reg-
ulatory regions (2.4 versus 0.67 sites per promoter; Fig-
ure 2C, Figure S4, and data not shown). Certain bZIP
transcription factors, including ATF-2 (Raingeaud et al.,
1995), CHOP/GADD153 (Wang and Ron, 1996), and
CREB (Tan et al., 1996; Yu et al., 2001), are activated by
p38 MAPK. Such factors may therefore mediate the p38
responsiveness of these genes.
CREB as a p38 MAPK-Regulated Transcription
Factor Required for Macrophage Survival
To identify the transcription factor targeted by p38 in
macrophages, we examined phosphorylation of indi-
vidual bZIP transcription factors as well as nuclear
translocation of NF-κB proteins in response to TLR
engagement. bZIP transcription factors activated by
phosphorylation were first analyzed in the nuclear frac-
tions of RAW264.7 macrophages with antibodies spe-
cific to their phosphorylated and active form (Figures
3A and 3B). This analysis revealed that CREB, c-Jun,and ATF-2 were transiently activated in response to
LPS. To test p38 MAPK dependence, RAW264.7 cells
were preincubated with SB202190 before LPS stimula-
tion. Among the bZIP proteins thus examined, only
CREB activation was blocked by the p38 inhibitor as
was previously found (Figure 3A). The p38 dependence
of LPS-induced CREB activation has been also shown
by others in another macrophage cell line, J774A.1
(Bradley et al., 2003). We confirmed that BMDMs incu-
bated with either SB202190 or anthrax LT did not acti-
vate CREB in response to LPS (Figure 3C).
CREB is activated through phosphorylation at serine
133 (S133) in response to stimuli, which act through
either protein kinase A (PKA) or other protein kinases
(Mayr and Montminy, 2001). The amino acid sequence
surrounding CREB S133 does not fit the consensus
recognized by MAPKs. Most likely, p38 activates an-
other protein kinase that phosphorylates CREB. Among
known CREB S133 kinases, MSK1 and MSK2 are acti-
vated by p38 in fibroblasts (Deak et al., 1998). To exam-
ine their role in p38-dependent CREB phosphorylation
in macrophages, we derived BMDMs from mice lacking
both MSK1 and MSK2 (Wiggin et al., 2002). LPS-induced
CREB phosphorylation in these double-knockout BMDMs
was severely diminished (Figure 3D), suggesting that
MSK1 and MSK2 are the major subordinate kinases
linking p38 to CREB activation in TLR4-activated ma-
crophages.
Immunity
322Figure 2. Identification of LPS-Inducible NF-
κB Target Genes that Require p38 Activity
(A) Expression of 35 LPS-inducible genes in
IkkbDmye BMDMs (IkkbDM) and SB202190-
treated C57BL/6J BMDMs (SB), at 4 hr
poststimulation, was analyzed by real-time
PCR. The values represent percentage of
mRNA in these samples relative to control
samples (IkkbF/F BMDMs and DMSO-treated
C57BL/6J BMDMs, respectively).
(B) BMDMs were stimulated with LPS in
the absence (DM-DMSO) or presence of
SB202190 (SB). After 4 hr, expression of the
indicated genes was analyzed by RNase
protection.
(C) Promoter organization of p38-independent
and -dependent NF-κB target genes. DNA se-
quences were obtained from the GenBank and
Celera genomic databases and analyzed
using TESS software (http://www.cbil.upenn.
edu/tess/). Transcription factor binding site se-
quences for the eight genes are listed in Fig-
ure S4.We next examined whether CREB mediates survival
of TLR4-activated macrophages. As gene disruption
failed to completely abolish CREB activity due to func-
tional redundancy with the closely related bZIP proteins
ATF1 and CREM (Hummler et al., 1994), we used
a highly specific dominant-negative CREB molecule,
ACREB, that inhibits the function of all CREB-related
proteins but has no effect on other bZIP transcription
factors (Ahn et al., 1998). Infection of BMDMs with an
ACREB lentivirus, but not with a control lentivirus ex-
pressing green fluorescent protein (GFP), resulted in a
small increase in basal apoptosis that was clearly en-
hanced by LPS, which had only a marginal effect on
viability of BMDMs infected with the GFP lentivirus (Fig-
ures 3E and 3F).
Anthrax Edema Factor Promotes CREB Activation
and Macrophage Survival
Since inhibition of CREB function sensitizes macro-
phages to LPS-induced apoptosis, we examined whether
CREB activation through an alternative pathway can
prevent TLR4-triggered apoptosis of macrophages whose
p38 pathway has been blocked. To activate CREB in a
p38-independent manner, we employed two agents
that elevate intracellular cAMP: anthrax ET, a bacterial
toxin whose catalytic subunit, edema factor (EF), has
adenylyl cyclase (AC) activity (Collier and Young, 2003);
and forskolin, an activator of endogenous AC (Seamon
et al., 1981). Elevation of cAMP is expected to activate
PKA, the first identified CREB S133 kinase (Gonzalez
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fnd Montminy, 1989). Treatment of BMDMs with either
T or forskolin induced CREB S133 phosphorylation
Figure 4A). CREB activation by ET was not blocked by
T and took place also in MSK1/MSK2-deficient
MDMs (Figure 4B). Thus, unlike LPS, cAMP activates
REB independently of p38 MAPK. Furthermore, ET
ctivated CREB in LPS-stimulated macrophages in
hich p38 signaling was blocked by LT (Figure 4C). Im-
ortantly, CREB activation by ET was accompanied by
nhanced survival of LT-exposed macrophages (Fig-
res 4D and 4E). Cell-permeable cAMP analogs also
rotected LT-treated macrophages from TLR4-induced
poptosis (Figure 4E). The survival-enhancing activity
f ET required CREB, as ET did not enhance survival of
CREB-expressing BMDMs that were incubated with
PS (Figure 4F). Hence, CREB is a point of con-
ergence for at least two antiapoptotic signaling path-
ays in macrophages, dependent upon either p38
APK or cAMP. These findings raise the interesting
ossibility that B. anthracis may control the timing of
acrophage apoptosis by modulating expression of its
wo toxin catalytic subunits LF and EF.
AI-2: A Transcriptional Target for p38,
REB, and NF-B
aving identified CREB as an antiapoptotic and p38-
esponsive transcription factor in activated macro-
hages, we searched for a transcriptional target for
REB that could act as a survival factor. Based on the
inding that most p38-dependent LPS-inducible genes
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323Figure 3. CREB Is a p38-Dependent Tran-
scription Factor Needed for Inhibition of
TLR4-Induced Macrophage Apoptosis
(A) RAW264.7 macrophages were treated
with LPS for the indicated duration in the
presence of either DMSO or SB202190, after
which cytoplasmic (Cyto) and nuclear (Nuc)
extracts were prepared and analyzed by im-
munoblotting with the antibodies indicated
on the left. Antibodies specific to the phos-
phorylated form (Phos) of the proteins were
used along with antibodies that recognize all
protein forms (Tot).
(B) The extracts used in (A) were analyzed
by immunoblotting with the antibodies that
detect cytoplasmic (IKKβ) and nuclear (Brg1
and CBP) proteins.
(C) BMDMs were preincubated with LT (500
ng/ml LF + 1 g/ml PA), SB202190 (SB; 10
M), SP600125 (SP; 20 M), and PD98059
(PD; 10 M) for 2 hr, and then treated with
LPS (100 ng/ml) for 30 min. Whole-cell ly-
sates were prepared and analyzed by immu-
noblotting as in (A).
(D) BMDMs from wt and Msk1/Msk2 dou-
ble knockout mice (DKO) were analyzed as
in (A).
(E and F) BMDMs were infected with lentivi-
ruses expressing GFP or ACREB. After 48 hr,
the cells were left unstimulated or stimulated
with LPS (100 ng/ml) for 24 hr. The extent of
apoptosis was determined by DNA fragmen-
tation and gel electrophoresis (E) or annexin
V staining (F). The data represent the aver-
age ± SD for three independent experiments.in macrophages also require IKKβ (Figure 2A), we pos-
tulated that such a target should also be dependent on
NF-κB. We therefore identified several p38-dependent
NF-κB target genes whose promoters contained obvi-
ous CREB binding sites (Figure 2C) and examined them
in further detail. The results described below pointed to
Pai-2, which encodes an endogenous serine protease
inhibitor, a member of the serpin family (Silverman et
al., 2001), as a likely candidate. Among the three ser-
pins that are most strongly induced upon LPS treat-
ment of BMDMs (Figure 5A), PAI-2 is the only one
whose induction requires both IKKβ and p38 (Figures
5B and 5C). Importantly, inhibition of CREB activity pre-
vented induction of Pai-2 mRNA by LPS but had no
effect on induction of another p38- and NF-κB-depen-
dent survival gene: Bfl-1/A1 (Figure 5D). SB202190 and
ACREB also inhibited induction of PAI-2 protein in
BMDMs stimulated with LPS (Figure 5E) or ALO (Figure
S1C). When LT-induced inhibition of CREB phosphory-
lation in LPS-stimulated macrophages was reversed by
ET (Figure 4C), induction of Pai-2 but not other p38-
dependent antiapoptotic genes was significantly re-
stored (Figure 5F).
To confirm that Pai-2 is a transcriptional target for
NF-κB and CREB, we carried out chromatin immuno-
precipitation (ChIP) experiments. Pai-2 contains single
putative NF-κB and CREB binding sites at −860 bp and
−1319 bp, respectively, within its control region (Figure
2B). The ChIP analysis revealed that CREB was effi-
ciently recruited to the Pai-2 regulatory region even
prior to LPS stimulation (Figure 5G). By contrast, CREBrecruitment could not be detected at the iNos and IkBa
promoters, whose activation was insensitive to ACREB
(data not shown). Although CREB was constitutively
present at the Pai-2 promoter, S133 phosphorylation of
promoter bound CREB was upregulated by LPS and
required p38 activity (Figure 5G). Basal phosphorylation
of CREB on the Pai-2 promoter prior to LPS stimulation
was found to originate from M-CSF signaling as it dis-
appeared upon withdrawal of M-CSF from the culture
medium (Figure S5). The NF-κB proteins RelA/p65 and
c-Rel were recruited to the Pai-2, IkBa, and iNos pro-
moters only after LPS stimulation (Figure 5G). Occu-
pancy of the Pai-2 promoter by NF-κB and phosphory-
lated CREB was accompanied by increased Pol II
recruitment, indicative of enhanced initiation of tran-
scription (Figure 5G). Although inhibition of p38 blocked
phosphorylation of promoter bound CREB without af-
fecting CREB recruitment, it did inhibit recruitment of
NF-κB proteins, and consequently Pol II, to the Pai-2
promoter (Figure 5G). By contrast, inhibition of p38 had
no effect on recruitment of NF-κB proteins or Pol II to
the iNos and IkBa regulatory regions.
PAI-2 Inhibits Apoptosis of TLR4-Activated
Macrophages
Having identified Pai-2 as a common transcriptional
target for several survival pathways, we examined its
antiapoptotic function in TLR4-activated macrophages.
Previously, PAI-2 was reported to antagonize mycobac-
terial and viral cytopathic effects in human macro-
phages and carcinoma cell lines (Gan et al., 1995; An-
Immunity
324Figure 4. cAMP Signaling Promotes Macro-
phage Survival by Restoring CREB Activa-
tion Independently of p38
(A) BMDMs were treated with ET or forskolin
(100 M) for the indicated duration. Whole-
cell lysates were prepared and analyzed by
immunoblotting.
(B) BMDMs from wt and Msk1/Msk2 double
knockout mice (DKO) were preincubated
without or with LT for 2 hr and then stim-
ulated with ET (500 ng/ml of EF + 1 g/ml
PA) for 2 hr. Whole-cell lysates were pre-
pared and analyzed as in (A).
(C) BMDMs were preincubated without or
with ET and LT for 2 hr as indicated and then
treated or not with LPS for 30 min. Whole-
cell lysates were prepared and analyzed as
in (A).
(D) BMDMs were preincubated without or
with ET and LT as in (C) and then treated with
LPS. After 24 hr, apoptotic macrophages
were scored by a TUNEL assay.
(E) BMDMs were preincubated with ET, LT,
and/or various cAMP analogs (100 M) as
indicated for 2 hr and then treated with LPS.
After 24 hr, cell viability was measured.
(F) BMDMs were left uninfected or infected
with lentiviruses expressing GFP or ACREB.
After 48 hr, cells were preincubated without
or with LT and ET as indicated and stim-
ulated with LPS as in (D) and cell viability
was measured. The data in (D)–(F) represent
the average ± SD for three independent ex-
periments.talis et al., 1998). Other studies showed that PAI-2
inhibits TNFα-induced apoptosis of human carcinoma
and fibrosarcoma cell lines (Dickinson et al., 1995; Ku-
mar and Baglioni, 1991), but we could not detect en-
hanced TNFα-induced apoptosis in p38α-deficient fi-
broblasts, although these cells did not respond to TNFα
with Pai-2 induction (data not shown). The first hint for
an antiapoptotic function for PAI-2 in TLR4-activated ma-
crophages was obtained by screening different chemical
inhibitors for their ability to enhance survival of LPS-stim-
ulated and p38-inhibited macrophages. In these experi-
ments, the serine protease inhibitor N-tosyl-L-phenylala-
nyl chloromethyl ketone (TPCK) protected p38-inhibited
macrophages from LPS-induced apoptosis (Figure S6).
More direct evidence for the survival function of PAI-2
was provided by analyzing macrophages derived from
the human promonocytic leukemia cell THP-1, which
carries a naturally occurring mutation in the PAI-2 gene
(Katsikis et al., 2000). Although THP-1-derived macro-
phages (TDMs) respond to TLR4 engagement with p38
and IKK activation and cytokine gene induction (data
not shown), they are highly susceptible to LPS-induced
apoptosis (Figure 6A). Unlike the situation in BMDMs
and RAW264.7 macrophages, TLR4-induced apoptosis
in TDMs does not require p38 inhibition (Figure S7). To
address whether the increased susceptibility to TLR4-
induced apoptosis is due to PAI-2 deficiency, we gener-
a
c
6
a
b
t
i
t
1
P
s
u
t
c
o
w
a
f
p
s
E
t
t
T
s
oted THP-1 derivatives stably expressing PAI-2. Such
ells were resistant to LPS-induced apoptosis (Figure
A). We also transduced TDMs with adenoviral vectors
nd found that TLR4-induced apoptosis was inhibited
y PAI-2 but not PAI-1 (Figure 6B). These data support
he hypothesis that PAI-2 is an important survival gene
n TLR4-activated human macrophages.
We extended our analyses to mouse BMDMs with a
argeted deletion of the Pai-2 gene (Dougherty et al.,
999). Consistent with the results described above,
ai-2−/− BMDMs exhibited a stronger apoptotic re-
ponse to LPS alone in comparison to wt BMDMs (Fig-
re 6C). However, this response was not as robust as
he one seen in IKKβ-deficient macrophages or wt ma-
rophages incubated with SB202190, suggesting that
ther antiapoptotic genes that depend on both path-
ays, for instance Bfl-1/A1, provide protection in the
bsence of PAI-2. To address this possibility, we trans-
ected RAW264.7 macrophages with various antiapo-
totic genes and tested their ability to prevent apopto-
is induced by treatment with LPS and SB202190.
xpression of either Bfl-1/A1 or PAI-2 enabled the
ransfected cells to survive selection in a medium con-
aining both LPS and SB202190 (Figures 6D and 6E).
reatment with either LPS or SB202190 alone under the
ame condition did not significantly reduce the viability
f RAW264.7 macrophages (data not shown). This pro-
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325Figure 5. TLR4-Mediated PAI-2 Induction
Depends on the IKKβ/NF-κB and p38/CREB
Modules
(A) Induction of different serpin mRNAs in
LPS-stimulated BMDMs was determined by
a DNA microarray experiment.
(B–D) Total RNA was isolated from the fol-
lowing cells and relative expression of vari-
ous mRNAs was determined by real-time
PCR. (B) IkkbF/F and IkkbDmye (IkkbDM)
BMDMs left unstimulated or stimulated with
LPS for 4 hr. (C) Wild-type BMDMs preincu-
bated with DMSO LT or SB202190 for 2 hr,
and then treated with LPS 4 hr. (D) Wild-type
BMDMs infected with lentiviruses express-
ing GFP or ACREB, and then left unstimu-
lated or stimulated with LPS for 4 hr.
(E) BMDMs were preincubated with DMSO
or SB202190 for 2 hr (left) or infected with
lentiviruses expressing GFP or ACREB for 48
hr (right). Cells were then treated with LPS
for the indicated duration. Whole-cell lysates
were prepared and immunoblotted with the
indicated antibodies.
(F) BMDMs were preincubated or not with LT
and/or ET for 2 hr, and then treated with LPS
for 4 hr. Relative expression of various
mRNAs was determined as in (B).
(G) BMDMs were preincubated with DMSO
or SB202190 for 2 hr and then left untreated
or treated with LPS before being fixed with
formaldehyde. Chromatin was prepared,
sonicated, and immunoprecipitated with the
indicated antibodies for ChIP analysis. Re-
cruitment of the different transcription fac-
tors and the large subunit of RNA polymer-
ase II (Pol II) was determined by PCR
analysis with primer sets specific to the indi-
cated gene promoters.tective effect was also seen with other Bcl-2 family
members, such as Bcl-2 (data not shown) and Bcl-XL,
but not with inhibitor of apoptosis (IAP) family members
(Figure 6E). Among Bcl-2 family members that con-
ferred apoptotic resistance to LPS+ SB202190-treated
macrophages, only Bfl-1/A1 expression depends on
both the IKK/NF-κB and p38 pathways (Figures 2A and
2B; Figure S8). Therefore, the importance of Bfl-1/A1
was further examined through loss-of-function experi-
ments. As functional Bfl-1/A1 protein is encoded by
three clustered genes in the mouse genome (Hatake-
yama et al., 1998), we performed RNA interference
(RNAi) with a lentivirus expressing a short hairpin (sh)
RNA that can knock down expression of all three Bfl-1/
A1 isoforms. In both wt and Pai-2−/− BMDMs, infection
with the A1 shRNA-containing lentivirus caused more
than 3-fold decrease in Bfl-1/A1 mRNA amount, similar
to the effect of the p38 inhibitor SB202190 (Figure 6F).
The knockdown of Bfl-1/A1 sensitized both wt and Pai-
2−/− BMDMs to TLR4-induced apoptosis, with the effect
on Pai-2−/− BMDMs similar to that of SB202190 on wt
macrophages (Figure 6G). These results strongly sug-
gest that Pai-2 and Bfl-1/A1 are critical p38-dependentantiapoptotic genes for preventing apoptosis of TLR4-
activated macrophages.
Discussion
Our previous (Park et al., 2002; Hsu et al., 2004) and
present studies define a critical innate immunity-asso-
ciated antiapoptotic response responsible for survival
of TLR4-activated macrophages (Figure 7). The new
findings described above indicate that in the antiapo-
ptotic branch of TLR4 signaling, the IKK/NF-κB and p38
MAPK modules cooperate to induce transcription of
two critical antiapoptotic genes, Pai-2 and Bfl-1/A1,
whose products block the concurrent activation of the
proapoptotic pathway. Unless opposed, this proapo-
ptotic pathway can bring about rapid macrophage
death and premature cessation of the innate immune
response. The ability of PAI-2 to inhibit TLR4-induced
macrophage apoptosis suggests a novel apoptotic
mechanism that is regulated by a serpin family member.
An antiapoptotic function for a serpin, however, is not
unprecedented. It was shown that the serpin Spi2A/
Spi2-1 promotes survival of cytotoxic T lymphocytes
Immunity
326Figure 6. PAI-2 Protects Macrophages from
LPS-Induced Apoptosis
(A) Macrophages derived from THP-1 cells
stably transfected with either empty (Neo;
open bars) or PAI-2 (solid bars) expression
vectors were treated with LPS. After 24 hr,
the percentages of apoptotic cells were de-
termined by staining with annexin V. The in-
set shows the level of PAI-2 expression.
(B) THP-1 cells infected with adenoviruses
expressing GFP, PAI-1, or PAI-2 were dif-
ferentiated into macrophages and stimulated
with LPS. After 24 hr, cell viability was mea-
sured. Inset: PAI-2 expression.
(C) Pai-2+/+ (wt) and Pai2−/− (KO) BMDMs
were left untreated or treated with LPS for 48
hr. The percentages of apoptotic cells were
determined as in (A). Inset: PAI-2 expression
in two different batches of KO BMDMs.
(D) RAW264.7 macrophages transfected with
the indicated amounts of GFP, Bfl-1/A1, or
PAI-2 expression vectors were cultured in
the presence of LPS plus SB202190. After 14
days, viable cells were visualized by Giemsa-
Wright staining.
(E) RAW264.7 macrophages were trans-
fected with the indicated expression vectors.
After 2 days, transfected cells were divided
into two culture dishes and cultured further
in the presence of G418 (1 mg/ml) or LPS
(100 ng/ml) plus SB202190 (20 M), respec-
tively. After 14 days, viable colonies were
visualized as in (D) and counted.
(F and G) Pai-2+/+ (wt) and Pai2−/− (KO)
BMDMs were infected with lentiviruses ex-
pressing: no shRNA (−), luciferase-specific
shRNA (Luc), or Bfl-1/A1 (A1)-specific
shRNA, and then stimulated with LPS for 24
hr. Relative expression of Pai-2 and Bfl-1/A1
mRNAs (F) was determined by real-time
PCR. The percentages of apoptotic cells (G)
were determined as in (A). For comparison,
wt BMDMs infected with the Luc lentivirus were preincubated with DMSO or SB202190 before LPS stimulation and analyzed in parallel. The
data in (A)–(C) and (G) represent the average ± SD for three independent experiments.during differentiation into memory CD8 T cells (Liu et
al., 2004). Moreover, the cowpox virus crmA gene,
which codes for a serpin (Ray et al., 1992), suppresses
apoptosis in a variety of cell types (Gagliardini et al.,
1994; Enari et al., 1995; Tewari et al., 1995). However, it
is unclear whether these serpins share regulatory tar-
gets and act through similar mechanisms.
Although different in mechanism, macrophage apo-
ptosis triggered by TLR4 is conceptually reminiscent of
responses elicited by type 1 TNF receptor (TNFR1) and
the T cell receptor (TCR), all of which activate survival
pathways alongside proapoptotic pathways. By cou-
pling an apoptotic signaling pathway to receptors that
are activated by immune stimuli (PAMPs, proinflamma-
tory cytokines, and antigens), immune cells can control
their life span and restrict the extent of their activation,
which can be inherently self-damaging.
Although IKKβ-deficient fibroblasts, hepatocytes, and
macrophages are extremely sensitive to either TLR4- or
TNFR1-induced apoptosis (Hsu et al., 2004; Li et al.,
1999), the mechanisms by which NF-κB counteracts apo-
ptosis are stimulus and cell type specific. For instance,
whereas PAI-2 is an important inhibitor of TLR4-
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unduced macrophage apoptosis, we did not observe an
ntiapoptotic function for PAI-2 in TNFR1-triggered fi-
roblast apoptosis. Also, inhibition of p38α has no ef-
ect on TNFR1-triggered fibroblast apoptosis, but it has
huge effect on survival of TLR4-triggered macro-
hages. Furthermore, RelA/p65-deficient fibroblasts
nd hepatocytes are highly susceptible to TNFR1-
nduced apoptosis (Beg et al., 1995), but unlike IKKβ-
eficient macrophages, RelA-deficient macrophages
re not hypersensitive to TLR4-induced apoptosis
A.H., unpublished results). In all likelihood, the differential
equirements for signal transducers and transcription
actors in prevention of TNFR1- and TLR4-induced
poptosis reflect the mechanistic dissimilarity of the
roapoptotic reactions that the two stimuli elicit.
Whereas the role of IKKβ-driven NF-κB activation in
nnate immunity has been well explored and is tightly
inked to its antiapoptotic function (Karin and Lin,
002), this work sheds new light on the role of p38 in
acrophage function and innate immunity. By regu-
ating CREB activity, through its subordinate kinases
SK1/2 and additional targets, p38 is an important reg-
lator of macrophage survival that is required for induc-
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327Figure 7. A Wiring Diagram Illustrating the Signaling Pathways
through which TLR4 Activation Inhibits Macrophage Apoptosis
Engagement of TLR4 triggers prosurvival and prodeath pathways.
The survival response depends on activation of IKK and p38 MAPK,
which synergize to induce transcription of two major antiapoptotic
genes, Bfl-1/AI and Pai-2. Induction of Pai-2 depends on activation
of two p38-subordinate kinases, MSK1/2, which phosphorylate and
activate transcription factor CREB. The latter can also be accom-
plished through activation of PKA in response to cAMP, whose pro-
duction is catalyzed by the EF subunit of anthrax ET. This response
can delay the onset of macrophage death triggered by the action
of LF, the catalytic subunit of anthrax LT, which prevents p38 acti-
vation by cleaving MKK6.tion of two critical antiapoptotic genes: Pai-2 and Bfl-
1/A1. Unlike IKKβ and NF-κB, which regulate numerous
proinflammatory and innate immune genes, the tran-
scriptional function of p38 is more limited. Nonetheless,
p38 activation is also of importance for other macro-
phage functions, such as phagocytosis (Blander and
Medzhitov, 2004; Doyle et al., 2004), which does not
depend on NF-κB activation (unpublished results). Al-
though the direct targets for p38 in the pathway that
leads to Pai-2 induction are MSK1/2, which are required
for CREB activation, its target in the pathway leading
to Bfl-1/A1 induction remains to be identified. Previous
work has shown that some NF-κB target genes may
depend on p38 for chromatin modification (Saccani et
al., 2002), and the Bfl-1/A1 locus may represent such
a target.
CREB and its target genes participated in a plethora
of biological processes such as glucose metabolism,
neuroendocrine control, neuronal development, and
synaptic plasticity (Mayr and Montminy, 2001). We have
found that, acting as an antiapoptotic transcription fac-
tor in macrophages, CREB is also involved in innate
immunity. In macrophages actively engaged in TLR4-
mediated immunity, CREB promotes survival, at least in
part, through induction of PAI-2. An antiapoptotic role
for CREB has also been demonstrated in other cell
types such as neurons (Bonni et al., 1999; Riccio et al.,1999; Lonze et al., 2002; Mantamadiotis et al., 2002),
colon cancer cells (Nishihara et al., 2004), and pancre-
atic β-cells (Jhala et al., 2003). It is noteworthy that,
unlike neurons and β-cells, where CREB activation
alone drives expression of survival genes such as Bcl-2
and IRS2, respectively (Jhala et al., 2003; Lonze et al.,
2002; Mantamadiotis et al., 2002), induction of Pai-2
gene transcription in macrophages requires activation
of both CREB and NF-κB. Conceivably, by linking the
CREB-dependent antiapoptotic response to IKK/NF-κB
activation, macrophages couple this response to innate
immune stimuli.
The ability of anthrax ET to restore CREB activity
when the activating signal from TLR4 is blocked by LT
raises an interesting possibility regarding inhalation
anthrax. B. anthracis interacts with macrophages in a
paradoxical manner: it induces killing of alveolar mac-
rophages to suppress innate immune responses, yet it
utilizes these cells as a medium for replication and as
a vehicle for spreading to regional lymph nodes en
route to a fatal systemic infection (Dixon et al., 1999).
While LF is responsible for inhibiting p38-dependent
antiapoptotic signaling and inducing the death of TLR4-
activated macrophages (Park et al., 2002), EF may be
used to delay this apoptotic response until B. anthracis
has replicated to a sufficiently high titer within the mac-
rophage. Consistent with this notion, EF prevents inhi-
bition of the CREB-dependent antiapoptotic response
without inducing expression of other CREB-indepen-
dent p38 and NF-κB target genes that are involved in
innate immunity. This selective restoration of CREB-
mediated survival could be important for keeping other
LT-sensitive immune responses inactive during the
course of B. anthracis infection.
Experimental Procedures
Mice and Macrophages
Ikkb−/− (Li et al., 1999), IkkbDmye (Greten et al., 2004), IkkaAA/AA (Cao
et al., 2001), and p38aF/F (Nishida et al., 2004) mice were described
previously. p38aDmye mice were generated by crossing p38aF/F
mice with LysM-Cre mice (Clausen et al., 1999). BMDMs and
FLDMs were prepared as described (Park et al., 2002). For infection
experiments, the B. anthracis Sterne strain 7702 (Hsu et al., 2004)
was grown and added to macrophage cultures as previously de-
scribed (Park et al., 2004).
Reagents
Recombinant LF, EF, and PA were expressed in and purified from
E. coli strain BL21 (DE3) bearing the appropriate plasmid con-
structs as described (Cunningham et al., 1998). LPS (E. coli) and
forskolin were from Sigma-Aldrich, MAPK inhibitors were from Cal-
biochem, and cAMP analogs were from BIOLOG.
Measurement of Apoptosis
TUNEL assays and Hoechst staining were performed as described
(Park et al., 2002). MTT assays and annexin V staining were per-
formed using an MTT kit and annexin V-Alexa 568, respectively,
according to manufacturer's instructions (Roche).
Protein and RNA Analysis
Whole-cell, cytoplasmic, and nuclear extracts for immunoblot
analysis were prepared and analyzed as described (Park et al.,
2004). Total RNA was isolated using RNAwiz (Ambion). Microarray
analysis was performed with Affymetrix mouse chips with probes
for more than 8000 genes and total RNAs from J774A.1 macro-
phages that had been unstimulated or stimulated with LPS for 4 hr.
RNA analysis using real-time PCR was performed as described
Immunity
328(Park et al., 2004). Individual primer sequences are available upon
request.
Chromatin Immunoprecipitation
ChIP assays were as described (Saccani and Natoli, 2002). Poly-
clonal antibodies to p65/RelA (C-20), c-Rel (C), and Pol II (N-19)
were from Santa Cruz. The sequences of the promoter-specific
primers (Pai-2, −1351 to −827 for NF-κB and CREB and −249 to
−40 for Pol II; IkBa, −207 to −79; iNos, −261 to −72; Bfl-1/A1, −428
to −173) and a detailed experimental protocol are available upon
request.
Lentiviral Vectors
To construct the lentiviral vectors for RNAi, oligonucleotides with
the following sequences were synthesized, annealed, and cloned
in pLentiLox3.7 as described (Rubinson et al., 2003): Bfl-1/A1, 5#-
tggaaatgctctttctcctcaattcaagagattgaggagaaagagcatttccttttttc-3#
and 5#-tcgagaaaaaaggaaatgctctttctcctcaatctcttgaattgaggagaaag
agcatttcca-3#; Luc, 5#-tgaaaattgtgtacctttagctttcaagagaagctaaagg
tacacaattttcttttttc-3# and 5#-tcgagaaaaaagaaaattgtgtacctttagcttc
tcttgaaagctaaaggtacacaattttca-3#. GFP-, ACREB-, and shRNA-
expressing lentiviruses were produced as described elsewhere
(Rubinson et al., 2003). For lentiviral infection, BMDMs were incu-
bated with viruses for 48 hr before LPS treatment.
Supplemental Data
Supplemental Data include eight figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/23/3/
319/DC1/.
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